Articles by Peter O'Donnell - Applied Clinical Trials

ADVERTISEMENT

Articles by Peter O'Donnell

Peter O'Donnell


Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.

Articles
Catching Up with Data Protection
July 21, 2014

The European Union's struggle to bring its data protection rules into the 21st century continues...

Grasping Banality Firmly in Future Pharma Policy
July 8, 2014

The European Union has managed to snatch defeat from the jaws of opportunity once more!

Out With the Old, In With...?
June 25, 2014

As the new European Parliament assembles for the start of its five-year term on July 1, many familiar faces will be missing.

The Other Side of Transparency
June 24, 2014

Amid all the heated discussions of transparency and the insistence on ever wider disclosure, an intriguing contrast is provided by a document signed by health ministers on June 20.

Questions and Hopes on New EU Drug Legislation
June 1, 2014

Claims of success for pharmacovigilance are under question, but hopes are higher for new clinical trials rules.

One Less EU Rule to be Followed - but Brussels Gets Few Plaudits
May 29, 2014

A European bid to impose additional limits on research involving human embryos has been defeated.

EMA: Damned if it Does, Damned if it Doesn't
May 20, 2014

EMA's crowning achievement in transparency?proactive release of clinical trials data?is only weeks from finalization.

Near and Far: The Multi-Faceted Implications for Pfizer-AstraZeneca
May 1, 2014

The Pfizer-AstraZeneca courtship raises many fascinating questions about the future shape of the international pharmaceutical industry, but it is also revealing some remarkable displays of parochialism.

Bending Over Backwards to Get Transparency Right
April 14, 2014

The European Medicines Agency is determined to minimize opposition to its next moves on releasing clinical trial data.

Advertisement

ADVERTISEMENT

Untitled Document
Click here